Skip to main content

Table 6 Rate of malignancies in different organs in all patients, by sex and genotype

From: Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)

Organs

5-year prevalence of malignancies in general population (per 100, 000)$, 25

All, n (%)

N = 65

Sex, n (%)

 

Mutation, n (%)

 

Overall

Male

Female

Male

(n = 23)

Female

(n = 42)

p value

TSC1

(n = 11)

TSC2

(n = 15)

p value

Kidney

13.4

16.5

10.3

31 (47.7)

11 (47.8)

20 (47.6)

NS

4 (36.4)

8 (53.3)

0.3176

Breast

181.8

181.8

7 (10.8)

0

7 (16.7)

0.0159

1 (9.1)

1 (6.7)

0.3961

Thyroid

26.2

11.2

41.4

6 (9.2)

0

6 (14.3)

0.0159

3 (27.3)

1 (6.7)

0.0104

Testis

7.4

7.4

5 (7.7)

5 (21.7)

0

0.0265

1 (9.1)

0

0.2230

Ovary

20.2

20.2

4 (6.2)

NA

4 (9.5)

NS

1 (9.1)

3 (20.0)

1.000

Bone, soft tissue

2 (3.1)

2 (8.7)

0

NS

0

1 (6.7)

1.000

Colon

62.8

67.4

58.0

2 (3.1)

0

2 (4.8)

NS

0

0

NE

Lung

27.9

34.1

21.6

2 (3.1)

0

2 (4.8)

NS

1 (9.1)

0

0.2230

Pancreas

3.7

3.9

3.5

2 (3.1)

2 (8.7)

0

NS

0

1 (6.7)

1.000

Brain (cerebral)

10.1

10.3

9.9

1 (1.5)

1 (4.3)

0

NS

0

0

NE

Eye

1 (1.5)

0

1 (2.4)

NS

0

0

NE

Liver

8.8

12.2

5.4

1 (1.5)

1 (4.3)

0

NS

0

0

NE

Skin*

12.7

13.1

12.2

1 (1.5)

1 (4.3)

0

0.4835

0

0

NE

  1. *Melanoma of skin. $5-year prevalence of malignancies have been presented for qualitative comparison between the general population and our cohort. NE, non-estimable; NS, not significant